Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The aim of the present study was to evaluate levels of soluble CD 163 in sera and fluids from rheumatoid arthritis (RA) patients and elucidate the mechanism that regulates the shedding of CD163. Levels of soluble CD163 in sera and fluids from RA patients were examined by a sandwich enzyme immunoassay and Western blotting. To determine the effects of tissue inhibitors of metalloproteinase (TIMPs) on the shedding of CD163 from monocytes/macrophages, levels of soluble CD163 in cultures of monocytes/macrophages and the expression of CD163 on monocytes/macrophages in the presence or absence of TIMPs were examined by a sandwich enzyme immunoassay and flow cytometry, respectively. The clinical marker that was most associated with serum levels of soluble CD163 was levels of CRP. TIMP-3, but not TIMP-1 or TIMP-2, inhibited the shedding of CD163 from monocytes/macrophages. It was shown that serum levels of soluble CD163 are a sensitive and reliable marker to monitor activated macrophages in synovitis from RA patients and the results imply that the responsible proteinase for the shedding of CD163 is not a member of the matrix metalloproteinases, but is likely to be a member of ADAMs.

Original publication

DOI

10.1046/j.1365-2249.2002.01963.x

Type

Journal article

Journal

Clin Exp Immunol

Publication Date

10/2002

Volume

130

Pages

156 - 161

Keywords

Adult, Aged, Animals, Antigens, CD, Antigens, Differentiation, Myelomonocytic, Arthritis, Rheumatoid, Autoimmune Diseases, Biomarkers, Cell Line, Dexamethasone, Female, Humans, Macrophages, Male, Middle Aged, Receptors, Cell Surface, Recombinant Fusion Proteins, Solubility, Spodoptera, Synovial Fluid, Tissue Inhibitor of Metalloproteinase-3, Transfection